Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | TPMT | P51580 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.35 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10322938 | 0.84 | HPGD (0.41) | ALDH1A1KDM4EGAAMAPTHPGD | |
| SCHEMBL1573216 | 0.82 | TPMT (0.52) | ALDH1A1KDM4ETPMTPTGS2 | |
| SCHEMBL10603556 | 0.80 | PPARA (0.47) | ALDH1A1KDM4EGAAMEN1KMT2A | |
| SCHEMBL11672950 | 0.80 | KDM4E (0.50) | ALDH1A1KDM4EGAAMAPTHPGD | |
| SCHEMBL2153655 | 0.79 | HSP90AA1 (0.36) | ALDH1A1GAATPMTGLRA1MAPT | |
| SCHEMBL8473100 | 0.78 | HMGCR (0.44) | ALDH1A1KDM4EGAATPMTMEN1 | |
| SCHEMBL2154378 | 0.77 | HSP90AA1 (0.35) | ALDH1A1MEN1KMT2AGLRA1 | |
| SCHEMBL9549933 | 0.76 | PTGS2 (0.46) | ALDH1A1KDM4EMEN1KMT2APTGS2 | |
| SCHEMBL219096 | 0.75 | TUBB4A (0.55) | ALDH1A1KDM4ETPMTMEN1KMT2A | |
| SCHEMBL4311603 | 0.75 | TPMT (0.39) | ALDH1A1KDM4EGAATPMTGLRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7875631-B2 | e.g.1-(3,5-dichlorophenyl)-2-formyl-6-methoxy-1,2,3,4-tetrahydroisoquinoline; to prevent and/or treat cancer and other abnormal cell growth, and metabolic as well as blood vessel proliferate disorders, in which uncontrolled expression of insulin-like growth factor-1 receptor is observed | ANALYTECON S.A. (CH) | 2011-01-25 | — | — | US | disclosed |
| US-4024273-A | Coronary vasodilator and anti-anginal compositions comprising substituted benzofurans and benzothiophenes and methods of producing coronary vasodilation and anti-anginal activity | SMITHKLINE CORPORATION (US) | 1977-05-17 | — | — | US | disclosed |
| US-3947470-A | CORONARY VASODILATORS, TREATMENT OF ANGINA PECTORIS | SMITHKLINE CORPORATION (US) | 1976-03-30 | — | — | US | disclosed |